Literature DB >> 28733135

Centrally Mediated Cardiovascular Actions of the Angiotensin II Type 2 Receptor.

U Muscha Steckelings1, Annette de Kloet2, Colin Sumners3.   

Abstract

Sustained increases in the activity of the sympathetic neural pathways that exit the brain and which increase blood pressure (BP) are a major underlying factor in resistant hypertension. Recently available information on the occurrence of angiotensin II type 2 receptors (AT2Rs) within or adjacent to brain cardiovascular control centers is consistent with findings that stimulation of these receptors lowers BP, particularly during hypertension of neurogenic origin. Until recently brain AT2R had not been considered by many to play a role in the central control of BP. Demonstration of these powerful antihypertensive effects of brain AT2R opens the door to reconsideration of their role in BP regulation, and their consideration as a novel therapeutic avenue for resistant hypertension.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  angiotensin II; angiotensin type 2 receptor; neurogenic hypertension; sympathetic nervous system; vasopressin

Mesh:

Substances:

Year:  2017        PMID: 28733135      PMCID: PMC5563271          DOI: 10.1016/j.tem.2017.06.002

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  43 in total

1.  The angiotensin II AT2 receptor is an AT1 receptor antagonist.

Authors:  S AbdAlla; H Lother; A M Abdel-tawab; U Quitterer
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

2.  Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk.

Authors:  M Horiuchi; W Hayashida; M Akishita; K Tamura; L Daviet; J Y Lehtonen; V J Dzau
Journal:  Circ Res       Date:  1999-04-30       Impact factor: 17.367

Review 3.  Central neural control of the cardiovascular system: current perspectives.

Authors:  Roger A L Dampney
Journal:  Adv Physiol Educ       Date:  2016-09       Impact factor: 2.288

4.  Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese Zucker rats.

Authors:  Quaisar Ali; Sanket Patel; Tahir Hussain
Journal:  Am J Physiol Renal Physiol       Date:  2015-04-08

Review 5.  The Role of Central Nervous System Mechanisms in Resistant Hypertension.

Authors:  Dagmara Hering; Markus Schlaich
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

6.  Overexpression of AT2R in the solitary-vagal complex improves baroreflex in the spontaneously hypertensive rat.

Authors:  Prashant J Ruchaya; Guilherme F Speretta; Graziela Torres Blanch; Hongwei Li; Colin Sumners; José V Menani; Eduardo Colombari; Débora S A Colombari
Journal:  Neuropeptides       Date:  2016-07-20       Impact factor: 3.286

7.  Immunohistochemical demonstration of angiotensin II receptors in rat brain by use of an anti-idiotypic antibody.

Authors:  J Pfister; D Felix; H Imboden
Journal:  Regul Pept       Date:  1993-03-19

8.  Angiotensin Type-2 Receptors Influence the Activity of Vasopressin Neurons in the Paraventricular Nucleus of the Hypothalamus in Male Mice.

Authors:  Annette D de Kloet; Soledad Pitra; Lei Wang; Helmut Hiller; David J Pioquinto; Justin A Smith; Colin Sumners; Javier E Stern; Eric G Krause
Journal:  Endocrinology       Date:  2016-06-06       Impact factor: 4.736

9.  AT2-receptor stimulation enhances axonal plasticity after spinal cord injury by upregulating BDNF expression.

Authors:  Pawel Namsolleck; Francesco Boato; Katja Schwengel; Ludovit Paulis; Katherine S Matho; Nathalie Geurts; Christa Thöne-Reineke; Kristin Lucht; Kerstin Seidel; Anders Hallberg; Björn Dahlöf; Thomas Unger; Sven Hendrix; U Muscha Steckelings
Journal:  Neurobiol Dis       Date:  2012-11-19       Impact factor: 5.996

10.  Vasopressin and oxytocin in control of the cardiovascular system.

Authors:  Nina Japundžić-Žigon
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

View more
  11 in total

1.  Angiotensin receptor expression revealed by reporter mice and beneficial effects of AT2R agonist in retinal cells.

Authors:  Amrisha Verma; Ping Zhu; Annette de Kloet; Eric Krause; Colin Sumners; Qiuhong Li
Journal:  Exp Eye Res       Date:  2019-08-23       Impact factor: 3.467

2.  Brain angiotensin type-1 and type-2 receptors: cellular locations under normal and hypertensive conditions.

Authors:  Colin Sumners; Amy Alleyne; Vermalí Rodríguez; David J Pioquinto; Jacob A Ludin; Shormista Kar; Zachary Winder; Yuma Ortiz; Meng Liu; Eric G Krause; Annette D de Kloet
Journal:  Hypertens Res       Date:  2019-12-18       Impact factor: 3.872

Review 3.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

4.  Glutamatergic neurons of the paraventricular nucleus are critical contributors to the development of neurogenic hypertension.

Authors:  Tyler Basting; Jiaxi Xu; Snigdha Mukerjee; Joel Epling; Robert Fuchs; Srinivas Sriramula; Eric Lazartigues
Journal:  J Physiol       Date:  2018-09-20       Impact factor: 5.182

Review 5.  GABA is a mediator of brain AT1 and AT2 receptor-mediated blood pressure responses.

Authors:  Alain G Dupont; Laura Légat
Journal:  Hypertens Res       Date:  2020-05-25       Impact factor: 3.872

6.  Investigation of the Role of AT2 Receptors in the Nucleus Tractus Solitarii of Normotensive Rats in Blood Pressure Control.

Authors:  Laura Légat; Ilse J Smolders; Alain G Dupont
Journal:  Front Neurosci       Date:  2019-06-05       Impact factor: 4.677

7.  AT1 Receptor Mediated Hypertensive Response to Ang II in the Nucleus Tractus Solitarii of Normotensive Rats Involves NO Dependent Local GABA Release.

Authors:  Laura Légat; Ilse Smolders; Alain G Dupont
Journal:  Front Pharmacol       Date:  2019-05-03       Impact factor: 5.810

Review 8.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Authors:  Lauren B Arendse; A H Jan Danser; Marko Poglitsch; Rhian M Touyz; John C Burnett; Catherine Llorens-Cortes; Mario R Ehlers; Edward D Sturrock
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

Review 9.  The renin-angiotensin system: going beyond the classical paradigms.

Authors:  Robson Augusto Souza Santos; Gavin Y Oudit; Thiago Verano-Braga; Giovanni Canta; Ulrike Muscha Steckelings; Michael Bader
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

Review 10.  Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.

Authors:  Jaroslav Hrenak; Fedor Simko
Journal:  Int J Mol Sci       Date:  2020-10-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.